Comment on "Neuromuscular Impairment at Different Stages of Human Sarcopenia" by Sarto et al.-The Authors' Reply.
No abstract available
COI Statement
The authors declare no conflicts of interest.
References:
Jones R. A., Ramadan A., Qutifan S., and Gillingwater T. H., “Comment on ‘Neuromuscular Impairment at Different Stages of Human Sarcopenia’ by Sarto et al.,” Journal of Cachexia, Sarcopenia and Muscle 15 (2024): 1–2.
Sarto F., Franchi M. V., McPhee J. S., et al., “Neuromuscular Impairment at Different Stages of Human Sarcopenia,” Journal of Cachexia, Sarcopenia and Muscle 15 (2024): 1797–1810.
Piasecki M., Garnés‐Camarena O., and Stashuk D. W., “Near‐Fiber Electromyography,” Clinical Neurophysiology 132 (2021): 1089–1104.
Monti E., Sarto F., Sartori R., et al., “C‐Terminal Agrin Fragment as a Biomarker of Muscle Wasting and Weakness: A Narrative Review,” Journal of Cachexia, Sarcopenia and Muscle 14 (2023): 730–744.
Pratt J., De Vito G., Segurado R., et al., “Plasma Neurofilament Light Levels Associate With Muscle Mass and Strength in Middle‐Aged and Older Adults: Findings From GenoFit,” Journal of Cachexia, Sarcopenia and Muscle 13 (2022): 1811–1820.